Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
暂无分享，去创建一个
C. Charpentier | C. Katlama | Y. Yazdanpanah | F. Raffi | M. Lê | G. Peytavin | D. Descamps | F. Mentré | V. Joly | R. Landman | A. Benalycherif | A. Cabié | G. Collin | C. Burdet